JTH/LinkedIn
Jun 23, 2026, 13:44
How Sickle Hemoglobin Fuels Thrombosis and Vascular Injury – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jintao Wang et al, published in Journal of Thrombosis and Haemostasis, adding:
“Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
In sickle cell disease mice, sickle hemoglobin shortens clotting time and drives venous thrombosis, while hemoglobinase (plasmepsin I) therapy reduces free hemoglobin and thrombus size.”
Title: Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
Authors: Jintao Wang, Paul Silaghi, Daniel T. Eitzman

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?